Catalyst Pharmaceuticals Income Statement (2010-2026) | CPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.04B	0.04B	0.04B	0.04B	0.05B	0.06B	0.06B	0.09B	0.10B	0.10B	0.11B	0.10B	0.12B	0.13B	0.14B	0.14B	0.15B	0.15B	0.15B	0.15B
Cost of Revenue (Quarter)	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.01B
Gross Profit (Quarter)	0.03B	0.03B	0.03B	0.04B	0.05B	0.05B	0.05B	0.08B	0.09B	0.09B	0.09B	0.09B	0.11B	0.11B	0.12B	0.12B	0.13B	0.13B	0.13B	0.13B
Operating items
Research & Development (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	0.08B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.03B	0.03B	0.03B	0.04B	0.05B	0.04B	0.05B	0.04B	0.05B	0.05B	0.05B	0.05B	0.05B
Other Operating Expenses (Quarter)	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.03B	0.03B	0.03B	0.03B	0.03B	0.04B	0.02B
Operating Expenses (Quarter)	0.02B	0.02B	0.03B	0.03B	0.02B	0.03B	0.03B	0.05B	0.05B	0.14B	0.07B	0.07B	0.07B	0.08B	0.08B	0.08B	0.08B	0.08B	0.09B	0.08B
Operating Income (Quarter)	0.02B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B	-0.04B	0.04B	0.03B	0.05B	0.05B	0.06B	0.06B	0.07B	0.07B	0.06B	0.07B
EBIT (Quarter)	0.02B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B	-0.04B	0.04B	0.03B	0.05B	0.05B	0.06B	0.06B	0.07B	0.07B	0.06B	0.07B
Non-operating items
Interest & Investment Income (Quarter)	0.00B	-0.00B	-0.00B	-0.00B	0.00B	0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B			0.00B	-0.00B	0.00B	-0.00B		0.00B
Other Non Operating Income (Quarter)	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.01B	0.00B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	-0.02B	0.01B
Net income details
EBT (Quarter)	0.02B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B	-0.04B	0.05B	0.03B	0.06B	0.06B	0.07B	0.07B	0.07B	0.07B	0.07B	0.08B
Tax Provisions (Quarter)	0.00B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	0.01B	-0.01B	0.03B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.01B	0.02B
Profit After Tax (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	-0.03B	0.03B	0.02B	0.04B	0.04B	0.06B	0.06B	0.05B	0.05B	0.05B	0.06B
Income from Continuing Operations (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	-0.03B	0.02B	0.02B	0.04B	0.04B	0.06B	0.06B	0.05B	0.05B	0.06B	0.06B
Consolidated Net Income (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	-0.03B	0.02B	0.02B	0.04B	0.04B	0.06B	0.06B	0.05B	0.05B	0.06B	0.06B
Income towards Parent Company (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	-0.03B	0.02B	0.02B	0.04B	0.04B	0.06B	0.06B	0.05B	0.05B	0.06B	0.06B
Net Income towards Common Stockholders (Quarter)	0.01B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	-0.03B	0.02B	0.02B	0.04B	0.04B	0.06B	0.06B	0.05B	0.05B	0.06B	0.06B
Additional items
EPS (Basic) (Quarter)	0.12	0.10	0.09	0.13	0.21	0.22	0.25	0.28	0.36	-0.29	0.16	0.20	0.35	0.37	0.47	0.47	0.43	0.43	0.51	0.52
EPS (Diluted) (Quarter)	0.11	0.10	0.09	0.12	0.20	0.20	0.23	0.26	0.33	-0.29	0.15	0.19	0.33	0.35	0.45	0.45	0.41	0.42	0.49	0.50
Shares Outstanding (Quarter)	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.10B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.12B	0.12B	0.12B	0.12B	0.12B	0.12B	0.12B
Shares Outstanding (Diluted) (Quarter)	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.11B	0.12B	0.12B	0.13B	0.12B	0.13B	0.13B	0.13B	0.13B	0.13B
EBITDA (Quarter)	0.02B	0.01B	0.01B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B	-0.04B	0.04B	0.03B	0.05B	0.05B	0.06B	0.06B	0.07B	0.07B	0.06B	0.07B
Interest Expenses (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.03B	0.03B	0.03B	0.00B	0.01B	0.01B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.01B
Tax Rate (Quarter)	23.39%	26.60%	27.35%	24.16%	23.46%	12.53%	22.83%	20.76%	22.16%	19.09%	63.52%	19.99%	26.88%	23.29%	24.60%	20.41%	24.80%	25.69%	13.28%	24.33%

Research Tools

Developers

Catalyst Pharmaceuticals Income Statement (2010-2026) | CPRX

Research Tools

Developers

Catalyst Pharmaceuticals Income Statement (2010-2026) | CPRX

Create an account

Sign In

Reset Password